FTC sues to block Amgen’s acquisition of Horizon Therapeutics
May 16, 2023 at 13:44 PM EDT
Deal could allow Amgen to "entrench the monopoly positions" of two Horizon medications, regulators say.
Photography by Christophe Tomatis